1. 828 Improved growth properties and immune surveillance in K-RAS G12V-transformed cells through overexpression of biglycan. (10th December 2020) Authors: Subbarayan, Karthikeyan; Leisz, Sandra; Massa, Chiara; Balina, Sravankumar; Müller, Anja; Wickenhauser, Claudia; Seliger, Barbara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 828 Improved growth properties and immune surveillance in K-RAS G12V-transformed cells through overexpression of biglycan. (9th November 2020) Authors: Subbarayan, Karthikeyan; Leisz, Sandra; Massa, Chiara; Balina, Sravankumar; Müller, Anja; Wickenhauser, Claudia; Seliger, Barbara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 868 PRELP-facilitated enhancement of MHC class I surface expression in B16F10 melanoma cells. (10th December 2020) Authors: Schäfer, Helene; Subbarayan, Karthikeyan; Seliger, Barbara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 868 PRELP-facilitated enhancement of MHC class I surface expression in B16F10 melanoma cells. (9th November 2020) Authors: Schäfer, Helene; Subbarayan, Karthikeyan; Seliger, Barbara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. (31st December 2023) Authors: Vaxevanis, Christoforos K.; Bauer, Marcus; Subbarayan, Karthikeyan; Friedrich, Michael; Massa, Chiara; Biehl, Katharina; Al-Ali, Haifa Kathrin; Wickenhauser, Claudia; Seliger, Barbara Journal: Oncoimmunology Issue: Volume 12:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. (31st December 2022) Authors: Subbarayan, Karthikeyan; Massa, Chiara; Leisz, Sandra; Steven, André; Bethmann, Daniel; Biehl, Katharina; Wickenhauser, Claudia; Seliger, Barbara Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. (3rd April 2018) Authors: Subbarayan, Karthikeyan; Leisz, Sandra; Wickenhauser, Claudia; Bethmann, Daniel; Massa, Chiara; Steven, André; Seliger, Barbara Journal: Oncoimmunology Issue: Volume 7:Number 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells. Issue 3 (24th March 2021) Authors: Subbarayan, Karthikeyan; Massa, Chiara; Lazaridou, Maria‐Filothei; Ulagappan, Kamatchi; Seliger, Barbara Journal: Clinical and translational medicine Issue: Volume 11:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗